Skip to main content
Ali Naji, MD, General Surgery, Philadelphia, PA, Hospital of the University of Pennsylvania

AliNajiMD

General Surgery Philadelphia, PA

Transplantation

Professor, Surgery, Perelman School of Medicine

Are you Dr. Naji?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 70 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Ali Naji, MD is a general surgeon in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Hospital of the University of Pennsylvania, Children's Hospital of Philadelphia, and Phoenixville Hospital.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Surgery, 1971 - 1976
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityInternship, Transitional Year, 1970 - 1971
  • Shiraz University of Medical Sciences
    Shiraz University of Medical SciencesClass of 1970

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1974 - 2024
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Researchers Discover How Pancreatic Cells Remodel Themselves to Reduce the Immune Response in Patients at Risk for T1D
    Researchers Discover How Pancreatic Cells Remodel Themselves to Reduce the Immune Response in Patients at Risk for T1DMarch 2nd, 2022
  • Underlying Mechanisms Behind Type 1 Diabetes Development and the Pancreas Uncovered
    Underlying Mechanisms Behind Type 1 Diabetes Development and the Pancreas UncoveredMarch 1st, 2022
  • Penn Study Uncovers How Pancreatic Cells Reprogram Themselves to Limit the Immune Response in Patients at Risk for Type 1 Diabetes
    Penn Study Uncovers How Pancreatic Cells Reprogram Themselves to Limit the Immune Response in Patients at Risk for Type 1 DiabetesFebruary 28th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations